Forimtech S.A. was founded in 2004 in Geneva (Switzerland). With more than 30 years of research experience in the field of particle detectors at CERN (European Organization for Nuclear Research), the founders decided to apply their know-how to the market of medical devices.
The company has devoted the first years on research and development with the principal goal to implement most recent developments in the field of particle physics into molecular imaging in medical applications. The technical and commercial advantages of novel technologies have been clearly proven in a number of national and international projects, and several patent applications were deposited by Forimtech.
In 2009 Forimtech entered a new phase – bringing its products to the market. This activity is supported by a grant from CTI (Swiss Commission for Innovative Technologies) in the framework of its “Science to Market” program.
In 2014 Forimtech started clinical trials in partnership with CHUV (Lausanne University Hospital).
In 2015 the company successfully obtained CE mark for two products.